Editors: Atta-ur-Rahman, Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 1

eBook: US $44 Special Offer (PDF + Printed Copy): US $363
Printed Copy: US $341
Library License: US $176
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-60805-626-2 (Print)
ISBN: 978-1-60805-161-8 (Online)
Year of Publication: 2010
DOI: 10.2174/97816080516181100101

Introduction

Frontiers in Anti-Cancer Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.

Foreword

This first Volume of “Frontiers in Anti-Cancer Drug Discovery” published under the Editorship of Prof. Atta-ur-Rahman and Prof. Dr. M. Iqbal Choudhary contains very useful reviews on the latest aspects of anti-cancer drug discovery and development. These articles have been contributed by an impressive group of authors, the majority of whom are well known for their own contributions. Most interestingly, these thirty reviews reflect the rapid changes in approaches towards drug discovery and development, based on the growing understanding of etiology of various cancers at the molecular level. Many of these review articles focus on inhibition of enzymes which play key roles in the on-set of cancer and its progression. Novel classes of compounds and emerging approaches, such as antiangiogenesis, are also the topic of some reviews. Each chapter is well written, up-to-date, adequately illustrated, extensively referenced, and nicely edited. Overall cancer is a complex disease, and this volume reflects the complexity involved in its treatment, as well as the need for a further understanding at the molecular and cellular levels, and designing treatments that target key mechanistic steps.

The authors and editors deserve appreciation for compiling such a scholarly treatise, which should be of benefit both to academic researchers and industrial R & D personnel.

John K. Buolamwini, Ph.D.
Professor
Department of Pharmaceutical Sciences
College of Pharmacy
University of Tennessee Health Science Center
847 Monroe Avenue, Suite 327
Memphis, TN 38163, USA
Tel: 901 448-7533
Fax: 901 448-6828
E-mail: jbuolamwini@uthsc.edu


RELATED BOOKS

.In Silico and In vitro Approaches to Screen the Anti-TB Activity of Benzothiazole Analogs.
.Anti-Obesity Drug Discovery and Development.
.Anti-Angiogenesis Drug Discovery and Development.
.Bioactive Phytochemicals: Drug Discovery to Product Development.